Home » Following FDA Registration of Facility, Agilent Stays Mum on Dx Plans

Following FDA Registration of Facility, Agilent Stays Mum on Dx Plans

Jul 07, 2011

This article has been corrected to remove a reference to Affymetrix's CytoScan HD product, which was incorrectly identified as Agilent's product.

By Tony Fong

NEW YORK (GenomeWeb News) – Will Agilent Technologies become the next big player in the diagnostics space?

Probably not, according to one Wall Street analyst.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Scan

Like Sears, But With Cells

Jay Shendure and his colleagues have developed a new method to more comprehensively identify human cell types, the NY Times reports.

Infertile Mouse No More

Researchers in the UK and Japan have shown that infertility in mice with three sex chromosomes can be overcome, according to the Guardian.

PGD Growth Spurt

China is embracing preimplantation genetic diagnosis, Nature News reports. 

This Week in PLOS

In PLOS this week: host genetic factors associated with cervical neoplasia progression, population patterns for an ancient flowering rainforest plant, and more.

What's Popular?

In Diagnostics

  1. Cancer Genetics Q2 Revenues Down 6 Percent; Acquires VivoPharm for $12M

Sponsorships

Privacy Policy.  Copyright © 2017 GenomeWeb LLC.  All Rights Reserved.